Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

Magnetic resonance imaging detection of lesion progression in adult patients with X-linked adrenoleukodystrophy.

Eichler F, Mahmood A, Loes D, Bezman L, Lin D, Moser HW, Raymond GV.

Arch Neurol. 2007 May;64(5):659-64.

PMID:
17502464
2.

Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy.

Eichler FS, Barker PB, Cox C, Edwin D, Ulug AM, Moser HW, Raymond GV.

Neurology. 2002 Mar 26;58(6):901-7.

PMID:
11914405
3.

Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy.

van Geel BM, Bezman L, Loes DJ, Moser HW, Raymond GV.

Ann Neurol. 2001 Feb;49(2):186-94.

PMID:
11220738
4.

Rapid exacerbation in an elderly case of adult-onset X-linked adrenoleukodystrophy with cerebral corticospinal tract involvement.

Saito T, Mizuno T, Watanabe T, Ida M, Nakase H.

Arch Neurol. 2008 Mar;65(3):416-7. doi: 10.1001/archneur.65.3.416. No abstract available.

PMID:
18332258
5.

MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy.

Fatemi A, Barker PB, Uluğ AM, Nagae-Poetscher LM, Beauchamp NJ, Moser AB, Raymond GV, Moser HW, Naidu S.

Neurology. 2003 Apr 22;60(8):1301-7.

PMID:
12707433
6.

Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy.

Loes DJ, Fatemi A, Melhem ER, Gupte N, Bezman L, Moser HW, Raymond GV.

Neurology. 2003 Aug 12;61(3):369-74.

PMID:
12913200
7.

X-linked adrenoleukodystrophy: the role of contrast-enhanced MR imaging in predicting disease progression.

Melhem ER, Loes DJ, Georgiades CS, Raymond GV, Moser HW.

AJNR Am J Neuroradiol. 2000 May;21(5):839-44.

8.

MR of childhood metachromatic leukodystrophy.

Kim TS, Kim IO, Kim WS, Choi YS, Lee JY, Kim OW, Yeon KM, Kim KJ, Hwang YS.

AJNR Am J Neuroradiol. 1997 Apr;18(4):733-8.

9.

Asymmetric cerebral lesion pattern in X-linked adrenoleukodystrophy.

Wang S, Wu JM, Cheng YS.

J Chin Med Assoc. 2006 Aug;69(8):383-6.

10.

Involvement of the pontomedullary corticospinal tracts: a useful finding in the diagnosis of X-linked adrenoleukodystrophy.

Barkovich AJ, Ferriero DM, Bass N, Boyer R.

AJNR Am J Neuroradiol. 1997 Jan;18(1):95-100.

11.

Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and biochemical observations on 12 patients.

Pai GS, Khan M, Barbosa E, Key LL, Craver JR, Curé JK, Betros R, Singh I.

Mol Genet Metab. 2000 Apr;69(4):312-22.

PMID:
10870849
12.

Cerebral X-linked adrenoleukodystrophy: follow-up with magnetic resonance imaging.

Gasparetto EL, Rosa JM, Davaus T, de Carvalho Neto A.

Arq Neuropsiquiatr. 2006 Dec;64(4):1033-5.

13.

Virchow-Robin spaces on magnetic resonance images of children with adrenoleukodystrophy.

Groeschel S, Brockmann K, Hanefeld F.

Eur J Paediatr Neurol. 2007 May;11(3):142-5. Epub 2007 Jan 24.

PMID:
17254818
14.

Adrenoleukodystrophy: clinical analysis of 9 Taiwanese children.

Liang JS, Lee WT, Hwu WL, Peng SS, Chu LW, Wang PJ, Shen YZ.

Acta Paediatr Taiwan. 2004 Sep-Oct;45(5):272-7.

PMID:
15868809
15.
16.

X-linked adrenoleukodystrophy: spinocerebellar variant.

Tan EK, Lim SH, Chan LL, Wong MC, Tan KP.

Clin Neurol Neurosurg. 1999 Jun;101(2):137-40.

PMID:
10467913
17.
18.

Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy?

Eichler FS, Ren JQ, Cossoy M, Rietsch AM, Nagpal S, Moser AB, Frosch MP, Ransohoff RM.

Ann Neurol. 2008 Jun;63(6):729-42. doi: 10.1002/ana.21391.

PMID:
18571777
19.

[Subtle brain abnormalities in adrenomyeloneuropathy].

Teriitehau C, Adamsbaum C, Merzoug V, Kalifa G, Tourbah A, Aubourg P.

J Radiol. 2007 Jul-Aug;88(7-8 Pt 1):957-61. French.

20.

Brain MRI and electrophysiologic abnormalities in preclinical and clinical adrenomyeloneuropathy.

Aubourg P, Adamsbaum C, Lavallard-Rousseau MC, Lemaitre A, Boureau F, Mayer M, Kalifa G.

Neurology. 1992 Jan;42(1):85-91.

PMID:
1734328

Supplemental Content

Support Center